Analysis of cardiovascular disease-related NF-κB-regulated genes and microRNAs in TNFα-treated primary mouse vascular endothelial cells.
- Author:
Hui ZHU
1
;
Yun LI
1
;
Mao-Xian WANG
1
;
Ju-Hong WANG
1
;
Wen-Xin DU
2
;
Fei ZHOU
1
Author Information
- Publication Type:Journal Article
- Keywords: Cardiovascular disease; Nuclear factor-κB (NF-κB); MicroRNA; Endothelial cell
- MeSH: Animals; Cardiovascular Diseases/genetics*; Cells, Cultured; Endothelial Cells/drug effects*; Gene Regulatory Networks; Mice; MicroRNAs/physiology*; NF-kappa B/physiology*; Tumor Necrosis Factor-alpha/pharmacology*
- From: Journal of Zhejiang University. Science. B 2019;20(10):803-815
- CountryChina
- Language:English
- Abstract: Activated nuclear factor-κB (NF-κB) plays an important role in the development of cardiovascular disease (CVD) through its regulated genes and microRNAs (miRNAs). However, the gene regulation profile remains unclear. In this study, primary mouse vascular endothelial cells (pMVECs) were employed to detect CVD-related NF-κB-regulated genes and miRNAs. Genechip assay identified 77 NF-κB-regulated genes, including 45 upregulated and 32 downregulated genes, in tumor necrosis factor α (TNFα)-treated pMVECs. Ten of these genes were also found to be regulated by NF-κB in TNFα-treated HeLa cells. Quantitative real-time PCR (qRT-PCR) assay confirmed the up-regulation of Egr1, Tnf, and Btg2 by NF-κB in the TNFα-treated pMVECs. The functional annotation revealed that many NF-κB-regulated genes identified in pMVECs were clustered into classical NF-κB-involved biological processes. Genechip assay also identified 26 NF-κB-regulated miRNAs, of which 21 were upregulated and 5 downregulated, in the TNFα-treated pMVECs. Further analysis showed that nine of the identified genes are regulated by seven of these miRNAs. Finally, among the identified NF-κB-regulated genes and miRNAs, 5 genes and 12 miRNAs were associated with CVD by miRWalk and genetic association database analysis. Taken together, these findings show an intricate gene regulation network raised by NF-κB in TNFα-treated pMVECs. The network provides new insights for understanding the molecular mechanism underlying the progression of CVD.
